Dominic J Allocco

A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial.

Gregg W Stone, P. Teirstein, G. Stone, 2011, Journal of the American College of Cardiology.

A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: Design and statistical methods of the PERSEUS clinical program

D. Kereiakes, K. Dawkins, Dean J Kereiakes, 2010, Trials.

A novel paclitaxel-eluting stent with an ultrathin abluminal biodegradable polymer 9-month outcomes with the JACTAX HD stent.

Georg Nickenig, N. Curzen, G. Nickenig, 2010, JACC. Cardiovascular interventions.

Strut Coverage and Vessel Wall Response to a New-Generation Paclitaxel-Eluting Stent With an Ultrathin Biodegradable Abluminal Polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI)

Hiram G Bezerra, Giuseppe Musumeci, Giulio Guagliumi, 2010, Circulation. Cardiovascular interventions.